Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhihang Tao
Preoperative Platelet-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio as Predictors of Clinical Outcome in Patients With Gallbladder Cancer
Scientific Reports
Multidisciplinary
Related publications
Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients With NSCLC
Materia Socio Medica
Assessment of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio and Platelet Count as Predictors of Long-Term Outcome After R0 Resection for Colorectal Cancer
Scientific Reports
Multidisciplinary
Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Bone Metastases
British Journal of Cancer
Cancer Research
Oncology
Neutrophil-To-Lymphocyte Ratio, Monocyte-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, and Mean Platelet Volume-To-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
Mediators of Inflammation
Immunology
Cell Biology
Inflammation With Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Restless Legs Syndrome
Turk Noroloji Dergisi
Neurology
Clinical Significance of Pre-Operative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio as Prognostic Factors for Patients With Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Risk of Thromboembolism in Patients With Lymphoma Receiving Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy
Przeglad Gastroenterologiczny
Gastroenterology
Role of Pretreatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy
Erciyes Medical Journal
Medicine
